In a prospective, single arm study, Lumenis IPL with OPT™ improved signs and symptoms of Dry Eye Disease due to MGD, and decreased tear levels of key inflammation markers. The decrease of two of these markers were correlated with improvement in meibum expressibility.
Arita et al. (2019): Therapeutic efficacy of intense pulsed light in patients with refractory meibomian gland dsyfunction
The results of a prospective, random control trial show the combination of Lumenis IPL with OPT™ and Meibomian Gland Expression (MGX) improves tear film homeostasis and ameliorates ocular symptoms in patients with refractory Meibomian Gland Dysfunction (MGD).
Yan et al. (2021): The Efficacy of Intense Pulsed Light Combined With Meibomian Gland Expression for the Treatment of Dry Eye Disease Due to Meibomian Gland Dysfunction: A Multicenter, Randomized Controlled Trial
In a prospective, multicenter, randomized control trial, Lumenis IPL with OPT™ combined with MGX significantly improved signs and symptoms of DED due to MGD.
Dell et al. (2017): Prospective evaluation of intense pulsed light and meibomian gland expression efficacy on relieving signs and symptoms of dry eye disease due to meibomian gland dysfunction
In a prospective single arm study, Lumenis IPL with OPT™ combined with MGX reduced the number and severity of symptoms and signs of dry eye disease in subjects with moderate to severe MGD.
Yang et al. (2021): Treatment of contact lens related dry eye with intense pulsed light
In a prospective paired-eye study of patients wearing contact lenses and experiencing contact lens related dry eye, eyes treated with Lumenis IPL with OPTTM improved in signs and symptoms of dry eye disease (DED).
Lumenis Launches OptiLIFT, a New DMSt Device to Address Lower Lid Laxity and Impaired Blinking.
Lumenis Be. Ltd., a leading energy-based medical device company for eye care and aesthetic solutions, announced today the launch of OptiLIFT™, a new, proprietary Dynamic Muscle Stimulation technology (DMSt™) for toning facial muscles to address lower lid laxity and impaired blinking without the need for surgery.
Bosley and Lumenis Partner to Introduce Breakthrough Hair Loss Solution, FoLix™, to the U.S.
Lumenis’ first-in-class, proprietary and FDA-cleared fractional laser technology for hair loss treatment has the power to transform the lives of millions of hair loss sufferers in the U.S.
The Business of Dry Eye: 4 Steps to Boosting Practice Profitability with In-Office Treatments
Researchers found that 20 tear cytokines decreased significantly after IPL treatment, illustrating how IPL suppresses DED’s vicious cycle of inflammation.
Ablative Lasers CO2
Ablative lasers generate beams of coherent light that are absorbed by the body’s tissue as energy. The energy is delivered through a narrow range of wavelengths, and in the target area, the energy causes temperature elevation which results in tissue evaporation or ablation. Ablative lasers effectively treat a broad range of skin conditions by removing all or part of the skin. The body’s natural healing processes then replace the damaged skin with new and healthy tissue. Although several types of ablative lasers exist, differing mainly by wavelength, CO2 lasers have long been considered the industry’s ‘Gold Standard’ for ablation, delivering an exceptional ratio between ablation and coagulation (heating tissue without evaporating it).
Skin
Skin resurfacing procedures use lasers to reduce the signs of aging and improve skin texture, laxity and tone. They are also used for scar and stretch mark reduction as well as for treatment of a variety of other cosmetic concerns. Skin resurfacing can be achieved with either ablative or non-ablative lasers (see Non-Ablative Skin Resurfacing). Ablative resurfacing removes thin layers of the skin and is ideal for patients seeking a dramatic improvement in a single session.